Rua Life Sci. Regulatory News (RUA)

RUA Life Sciences Plc

("RUA Life Sciences", the "Company" or the "Group")

Investor Event

RUA Life Sciences, the holding company of a group of medical device businesses focused on the exploitation of the world's leading long-term implantable biostable polymer (Elast-EonTM), is pleased to announce an investor event on Wednesday 3rd November at 2.00pm.

Bill Brown, Chairman and Dr Caroline Stretton, Group MD will be joined by other key members of the management team. The event will be an opportunity for investors to hear directly from the company about the Vascular graft range, and discuss learnings from the October annual meeting of the European Association of Cardiothoracic Surgeons (EACTS) and latest 'in vivo' testing developments ahead of their 510k submission. Investors will also be able to get a closer look at the new site that will enable expansion of their manufacturing capacity and further dedicated R&D labs.

This event is open to all existing and potential shareholders and registration is free. Questions can be submitted during the presentation and will be addressed at the end of it.

To register for the event, please click here

 For more information please contact:

 Equity Development